Matriks Biotek/艾美捷針對(duì)抗體藥的ELISA試劑盒代理方案

Matriks Biotek專門生產(chǎn)針對(duì)抗體藥的ELISA試劑盒，用于檢測抗體藥的體內(nèi)濃度或因使用抗體藥而產(chǎn)生的抗體的體內(nèi)濃度。Matriks Biotek產(chǎn)品達(dá)到ISO 13485 & CE IVD標(biāo)準(zhǔn)。目前，在30個(gè)國家有超過25個(gè)的大型制藥企業(yè)都在使用其產(chǎn)品。

抗體藥（Monoclonal Antibody Drugs）是一類相對(duì)新型的生物制劑，是一類使用人工合成的單克隆抗體作為藥物治療的藥物?？贵w藥這些抗體藥物通過特異性地結(jié)合目標(biāo)分子或細(xì)胞表面受體，發(fā)揮治療作用?？贵w藥物具有高度的特異性和親和力，可以選擇性地結(jié)合目標(biāo)分子或細(xì)胞表面受體，從而干擾或調(diào)節(jié)生物過程。因此，檢測抗體藥血藥濃度及機(jī)體針對(duì)抗體藥產(chǎn)生的抗體水平對(duì)指導(dǎo)治療和個(gè)性化用藥具有重要意義。目前，大量的臨床和制藥企業(yè)都在從事該項(xiàng)研究。   

抗體藥物已被廣泛應(yīng)用于多種疾病的治療，包括腫瘤、自身免疫性疾病、傳染病等。它們可以作為單獨(dú)的治療藥物使用，也可以與其他藥物聯(lián)合應(yīng)用，以增強(qiáng)治療效果。   

下圖為Matriks Biotek授權(quán)艾美捷科技有限公司（AmyJet Scientific Inc.）作為Matriks Biotek在中國區(qū)域的代理授權(quán)書。

艾美捷Matriks Biotek特色推薦：

MTB-COR-QNS-IGG-SRBD CORONAHUNTER (Q-CORSRBD IgG) anti-Spike RBD IgG ELISA

MTB-COR-QNS-IGG-S1 CORONAHUNTER (Q-CORS1 IgG) anti-Spike 1 IgG ELISA

MTB-COR-QNS-IGG-NCP CORONAHUNTER (Q-CORN IgG) anti-Nucleocapsid IgG  ELISA

MTB-COR-QNS-IGG-STRIM CORONAHUNTER (Q-CORS IgG) anti-S Trimer IgG ELISA

MTB-COR-QNS-IGM-SRBD CORONAHUNTER (Q-CORSRBD IgM) anti-Spike RBD IgM ELISA

MTB-COR-QNS-IGM-S1 CORONAHUNTER (Q-CORS1 IgM) anti-Spike 1 IgM ELISA

MTB-COR-QNS-IGM-NCP CORONAHUNTER (Q-CORN IgM) anti-Nucleocapsid IgM  ELISA

MTB-COR-QNS-IGM-STRIM CORONAHUNTER (Q-CORS IgM) anti-S Trimer IgM ELISA

MTB-COR-QNS-IGA-SRBD CORONAHUNTER (Q-CORSRBD IgA) anti-Spike RBD IgA ELISA

MTB-COR-QNS-IGA-S1 CORONAHUNTER (Q-CORS1 IgA) anti-Spike 1 IgA ELISA

MTB-COR-QNS-IGA-NCP CORONAHUNTER (Q-CORN IgA) anti-Nucleocapsid IgA ELISA

MTB-COR-QNS-IGA-STRIM CORONAHUNTER (Q-CORS IgA) anti-S Trimer IgA ELISA

MTB-COR-QNS-IGE-SRBD CORONAHUNTER (Q-CORSRBD IgE) anti-Spike RBD IgE ELISA

MTB-COR-QNS-IGE-S1 CORONAHUNTER (Q-CORS1 IgE) anti-Spike 1 IgE ELISA

MTB-COR-QNS-IGE-NCP CORONAHUNTER (Q-CORN-SRBD IgE) anti-Nucleocapsid-S RBD IgE ELISA

MTB-COR-QNS-IGE-STRIM CORONAHUNTER (Q-CORS IgE) anti-S Trimer IgE ELISA

MTB-INF-FD-REMI Shikari (Q-INFLIXI) Infliximab (Remicade) ELISA

MTB-INF-SPEC-INF Shikari (QS-INFLIXI) Infliximab (Remicade) ELISA

MTB-INF-QLS-REMI Shikari (Q-ATI) Infliximab (Remicade) ELISA

MTB-INF-QNS-REMI Shikari (Q-ATI) w/confirmation Infliximab (Remicade) ELISA

MTB-INF-QNFT-REMI Shikari (Q-ATIDUO) Infliximab (Remicade) ELISA

MTB-INF-FD-REMS Shikari (Q-REMS) Infliximab (Remsima) ELISA

MTB-INF-QLS-REMS Shikari (S-AIR) Qualitative Infliximab (Remsima) ELISA

MTB-INF-QNS-REMS Shikari (S-AIR) w/confirmation Infliximab (Remsima) ELISA

MTB-INF-QNFT-REMS Shikari (S-AIR) Total semiquantitative Infliximab (Remsima) ELISA

MTB-ADA-FD-HUM Shikari (Q-ADA) Adalimumab (Humira) ELISA

MTB-ADA-SPEC-ADA Shikari (QS-ADA) Adalimumab (Humira) ELISA

MTB-ADA-QLS-HUM Shikari (S-ATA)-Qualitative Adalimumab (Humira) ELISA

MTB-ADA-QNS-HUM Shikari (S-ATA) w/confirmation Adalimumab (Humira) ELISA

MTB-ADA-QNFT-HUM Shikari (S-ATA)-Free/Total semiquantitative Adalimumab (Humira) ELISA

MTB-ETA-FD-ENB Shikari (Q-ETA) Etanercept (Enbrel) ELISA

MTB-ETA-QLS-ENB Shikari (S-ATE) Etanercept (Enbrel) ELISA

MTB-GOL-FD-SIM Shikari (Q-GOL) Golimumab (Simponi) ELISA

MTB-GOL-QLS-SIM Shikari (S-ATG) Golimumab (Simponi) ELISA

MTB-GOL-QNS-SIM Shikari (S-ATG) w/confirmation Golimumab (Simponi) ELISA

MTB-CER-FD-CIM Shikari (Q-CERT) Certolizumab (Cimzia) ELISA

MTB-CER-QNS-CIM Shikari (S-ATCER) Certolizumab (Cimzia) ELISA

MTB-VED-SPEC-VED Shikari (QS-VEDO) Vedolizumab (Entyvio) ELISA

MTB-VED-FD-ENT Shikari (Q-VEDO) Vedolizumab (Entyvio) ELISA

MTB-VED-QLS-ENT Shikari (S-ATV) Vedolizumab (Entyvio) ELISA

MTB-VED-QNS-ENT Shikari (S-ATV) w/confirmation Vedolizumab (Entyvio) ELISA

MTB-UST-FD-STE Shikari (Q-UST) Ustekinumab (Stelara) ELISA

MTB-UST-SPEC-STE Shikari (QS-UST) Ustekinumab (Stelara) ELISA

MTB-UST-QLS-STE Shikari (S-ATU) Ustekinumab (Stelara) ELISA

MTB-UST-QNS-STE Shikari (S-ATU) w/confirmation Ustekinumab (Stelara) ELISA

MTB-RAM-FD-CYR Shikari (Q-RAM) Ramucirumab (Cyramza) ELISA

MTB-RAM-QLS-CYR Shikari (S-ATRAM) Ramucirumab (Cyramza) ELISA

MTB-BEV-FD-AA Shikari (Q-BEVA) Bevacizumab (Avastin) ELISA

MTB-BEV-QLS-AA Shikari (S-ATB) Bevacizumab (Avastin) ELISA

MTB-BEV-QNS-AA Shikari (S-ATB) w/confirmation Bevacizumab (Avastin) ELISA

MTB-RIT-FD-RM Shikari (Q-RITUX) Rituximab (Rituxan, Mabthera) ELISA

MTB-RIT-QLS-RM Shikari (S-ATR) Rituximab (Rituxan, Mabthera) ELISA

MTB-RIT-QNS-RM Shikari (S-ATR) w/confirmation Rituximab (Rituxan, Mabthera) ELISA

MTB-TRA-FD-HH Shikari (Q-TRAS) Trastuzumab (Herceptin, Herclon) ELISA

MTB-TRA-QLS-HH Shikari (S-ATT) Trastuzumab (Herceptin, Herclon) ELISA

MTB-TRA-QNS-HH Shikari (S-ATT) w/confirmation Trastuzumab (Herceptin, Herclon) ELISA

MTB-CET-FD-ERB Shikari (Q-CET) Cetuximab (Erbitux) ELISA

MTB-CET-QLS-ERB Shikari (S-ATC) Cetuximab (Erbitux) ELISA

MTB-CET-QNS-ERB Shikari (S-ATC) w/confirmation Cetuximab (Erbitux) ELISA

MTB-DEN-FD-PRO Shikari (Q-DEN) Denosumab (Prolia) ELISA

MTB-DEN-QLS-PRO Shikari (S-ATD) Denosumab (Prolia) ELISA

MTB-DEN-QNS-PRO Shikari  (S-ATD) w/confirmation Denosumab (Prolia) ELISA

MTB-FIL-QNS-FRA Shikari (Q-AFA) Filgrastim ELISA

MTB-OMA-FD-XOL Shikari (Q-OMA) Omalizumab (Xolair) ELISA

MTB-OMA-QLS-XOL Shikari (S-ATO) Omalizumab (Xolair) ELISA

MTB-RAN-FD-LUC Shikari (Q-RAN) Ranibizumab (Lucentis) ELISA

MTB-AVE-FD-BAV Shikari (Q-AVE) Avelumab (Bavencio) ELISA

MTB-AVE-QLS-BAV Shikari (S-ATAV) Avelumab (Bavencio) ELISA

MTB-NIV-FD-OPD Shikari (Q-NIVO) Nivolumab (Opdivo) ELISA

MTB-NIV-QLS-OPD Shikari (S-ATN) Nivolumab (Opdivo) ELISA

MTB-NIV-QNS-OPD Shikari (S-ATN) w/confirmation Nivolumab (Opdivo) ELISA

MTB-PEM-FD-KEY Shikari (Q-PEM) Pembrolizumab (Keytruda) ELISA

MTB-PEM-QLS-KEY Shikari (S-ATP) Pembrolizumab (Keytruda) ELISA

MTB-PEM-QNS-KEY Shikari (S-ATP) w/confirmation Pembrolizumab (Keytruda) ELISA

MTB-IPI-FD-YER Shikari (Q-IPI) Ipilimumab (Yervoy) ELISA

MTB-IPI-QLS-YER Shikari (S-ATI) Ipilimumab (Yervoy) ELISA

MTB-IPI-QNS-YER Shikari (S-ATI) w/confirmation Ipilimumab (Yervoy) ELISA

MTB-TOC-FD-ACT Shikari (Q-TOC) Tocilizumab (Actemra) ELISA

MTB-TOC-QLS-ACT Shikari (S-ATOC) Tocilizumab (Actemra) ELISA

MTB-TOC-QNS-ACT Shikari (S-ATOC) w/confirmation Tocilizumab (Actemra) ELISA

MTB-NAT-FD-TYS Shikari (Q-NAT) Natalizumab (Tysabri) ELISA

MTB-NAT-QLS-TYS Shikari (S-ATNAT) Natalizumab (Tysabri) ELISA

MTB-NAT-QNS-TYS Shikari (S-ATNAT) w/confirmation Natalizumab (Tysabri) ELISA

MTB-AFL-FD-EYL Shikari (Q-AF) Aflibercept (Eylea) ELISA

MTB-AFL-FD-SENS-EYL Shikari (Q-AF) High Sensitive Aflibercept (Eylea) ELISA

MTB-AFL-QLS-EYL Shikari (S-ATAF) Aflibercept (Eylea) ELISA

MTB-AFL-QNS-EYL Shikari (S-ATAF) w/confirmation Aflibercept (Eylea) ELISA

MTB-CAN-FD-ILA Shikari (Q-CAN) Canakinumab (Ilaris) ELISA

MTB-CAN-QLS-ILA Shikari (S-ATCAN) Canakinumab (Ilaris) ELISA

MTB-CAN-QNS-ILA Shikari (S-ATCAN) w/confirmation Canakinumab (Ilaris) ELISA

MTB-DUR-FD-IMF Shikari (Q-DUR) Durvalumab (Imfinzi) ELISA

MTB-DUR-QLS-IMF Shikari (S-ATDUR) Durvalumab (Imfinzi) ELISA

MTB-ATE-FD-TEC Shikari (Q-ATE) Atezolizumab (Tecentriq) ELISA

MTB-ATE-QLS-TEC Shikari (S-ATAT) Atezolizumab (Tecentriq) ELISA

MTB-DAR-FD-DAR Shikari (Q-DAR) Daratumumab (Darzalex) ELISA

MTB-DAR-QLS-DAR Shikari (S-ATDAR) Daratumumab (Darzalex) ELISA

MTB-ABA-FD-ORE Shikari (Q-ABA) Abatacept (Orencia) ELISA

MTB-ABA-QLS-ORE Shikari (S-ATAB) Abatacept (Orencia) ELISA

MTB-ABA-QNS-ORE Shikari (S-ATAB) w/confirmation Abatacept (Orencia) ELISA

MTB-SEC-FD-VER Shikari (Q-SEC) Secukinumab (Cosentyx , Verxant) ELISA

MTB-SEC-QLS-VER Shikari (S-ATSEC) Secukinumab (Cosentyx , Verxant) ELISA

MTB-EVO-FD-REP Shikari (Q-EVO) Evolocumab (Repatha ) ELISA

MTB-EVO-QLS-REP Shikari (S-ATEVO) Evolocumab (Repatha ) ELISA

MTB-PAL-FD-SYN Shikari (Q-PAL) Palivizumab (Synagis ) ELISA

MTB-PAL-QLS-SYN Shikari (S-ATPAL) Palivizumab (Synagis ) ELISA

MTB-PAL-QNS-SYN Shikari (S-ATPAL) w/confirmation Palivizumab (Synagis ) ELISA

MTB-IXE-FD-TAL Shikari (Q-IXE) Ixekizumab (Taltz ) ELISA

MTB-IXE-QLS-TAL Shikari (S-ATIXE) Ixekizumab (Taltz ) ELISA

MTB-PER-FD-PER Shikari (Q-PER) Pertuzumab (Perjeta ) ELISA

MTB-PER-QLS-PER Shikari (S-ATPER) Pertuzumab (Perjeta ) ELISA

MTB-RIS-FD-SKY Shikari (Q-RIS) Risankizumab (Skyrizi ) ELISA

MTB-RIS-QLS-SKY Shikari (S-ATRIS) Risankizumab (Skyrizi ) ELISA

MTB-RIS-QNS-SKY Shikari (S-ATRIS) w/confirmation Risankizumab (Skyrizi ) ELISA

MTB-ECU-FD-SOL Shikari (Q-ECU) Eculizumab (Soliris ) ELISA

MTB-ECU-QLS-SOL Shikari (S-ATEC) Eculizumab (Soliris ) ELISA

MTB-ECU-QNS-SOL Shikari (S-ATEC) w/confirmation Eculizumab (Soliris ) ELISA

艾美捷科技是Matriks Biotek的中國代理商，為科研工作者提供優(yōu)質(zhì)的產(chǎn)品與服務(wù)。